Moderna, Inc. (MRNA) Margin Analysis - Discounting Cash Flows
MRNA
Moderna, Inc.
MRNA (NASDAQ)

Years and Quarters

Years

Years

The number of historical years used to render the annual chart and tables.

Quarters

Quarters

The number of historical quarters used to render the quarterly chart and tables.

Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (example: Net Income Margin = Net Income / Revenue).

This analysis provides annual and quarterly sections for reporting key financial margins.

Annual Section

The annual section uses annual data to calculate margins and growth rates.

Monetary values in USD

amounts except #

LTM
Mar 09
2025
Dec 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
Revenue 1,943 1,944 3,199 6,848 18,875
Revenue Growth Rate -0.051% -39.23% -53.29% -63.72% 6.42%
Cost of Revenue 1,669 868 1,464 4,693 5,416
Gross Profit 274 1,076 1,735 2,155 13,459
Gross Margin 14.1% 55.35% 54.24% 31.47% 71.31%
Operating Income -3,074 -3,074 -3,945 -4,239 9,420
Operating Margin -158.2% -158.1% -123.3% -61.9% 49.91%
Net Income -2,822 -2,822 -3,561 -4,714 8,362
Net Margin -145.2% -145.2% -111.3% -68.84% 44.3%

Monetary values in USD

amounts except #

LTM
Mar 09
2025
Dec 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
Revenue 1,943 1,944 3,199 6,848 18,875
Cash from Operating Activities -1,852 -1,873 -3,004 -3,118 4,981
Cash from Operating Activities Margin -95.32% -96.35% -93.9% -45.53% 26.39%
Free Cash Flow -2,054 -2,065 -4,055 -3,825 4,581
Free Cash Flow Margin -105.7% -106.2% -126.8% -55.86% 24.27%
Depreciation and Amortization 96 215 189 621 348
Depreciation and Amortization Margin 4.94% 11.06% 5.91% 9.07% 1.84%
Capital Expenditure -202 -192 -1,051 -707 -400
Capital Expenditure Margin -10.4% -9.88% -32.85% -10.32% -2.12%

Annual Chart

Monetary values in USD

Quarterly Section

The quarterly section uses quarterly data to calculate margins and growth rates.

Monetary values in USD

amounts except #

2025 (Q4)
Dec 31
2025 (Q3)
Sep 30
2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
Revenue 678 1,016 142 107 956 1,855
Revenue Growth Rate -33.27% 615.5% 32.71% -88.81% -48.46%
Cost of Revenue 452 1,008 119 90 739 514
Gross Profit 226 8 23 17 217 1,341
Gross Margin 33.33% 0.787% 16.2% 15.89% 22.7% 72.29%
Operating Income -857 -260 -907 -1,050 -1,246 -70
Operating Margin -126.4% -25.59% -638.7% -981.3% -130.3% -3.77%
Net Income -826 -200 -825 -971 -1,120 13
Net Margin -121.8% -19.69% -581% -907.5% -117.2% 0.701%

Monetary values in USD

amounts except #

2025 (Q4)
Dec 31
2025 (Q3)
Sep 30
2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
Revenue 678 1,016 142 107 956 1,855
Cash from Operating Activities 951 -847 -919 -1,037 825 -1,566
Cash from Operating Activities Margin 140.3% -83.37% -647.2% -969.2% 86.3% -84.42%
Free Cash Flow 912 -880 -922 -1,164 303 -1,717
Free Cash Flow Margin 134.5% -86.61% -649.3% -1,088% 31.69% -92.56%
Depreciation and Amortization 0 0 57 39 60 52
Depreciation and Amortization Margin 0% 0% 40.14% 36.45% 6.28% 2.8%
Capital Expenditure -39 -33 -3 -127 -522 -151
Capital Expenditure Margin -5.75% -3.25% -2.11% -118.7% -54.6% -8.14%

Quarterly Chart

Monetary values in USD

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program